Podcast 14 Feb 2025Reversing cancer mechanisms to fight back against solid tumors This week, we have a conversation with Catalym’s Eugen Leo about Visugromab is a monoclonal antibody that neutralizes the tumor-derived growth differentiation factor-15. February 14, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Best in Biotech 13 Feb 2025 Seven companies using metabolomics to decode biology Discover seven companies operating in metabolomics, the field that could significantly boost precision medicine. February 13, 2025 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 13 Feb 2025 DeepMind AlphaFold’s alumnus raises $40m for Latent Labs, a new AI biotech startup Find out about a new AI-driven company that emerges from stealth today to create novel protein – Latent Labs. February 13, 2025 - 6 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 12 Feb 2025 Dendritic cell therapy: Diakonos, Northwest Biotherapeutics and Mendus push ahead with next-generation candidates Find out about the field of dendritic cell therapy, as several companies attempt to bring next-generation candidates through the clinic. February 12, 2025 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 11 Feb 2025 12 ways biotechnology makes the world more sustainable Biotech companies are turning to biology for solutions to make all aspects of our lives more sustainable for the environment. February 11, 2025 - 11 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 10 Feb 2025 Monoclonal antibodies: are they the key to treating Alzheimer’s disease? A major stride in treating Alzheimer’s disease has been the development of monoclonal antibodies. February 10, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Reports Produced by Inpart 7 Feb 2025Partnering 2030: FME Industries Report Download Inpart’s new report to discover key challenges in the Food, Material, and Electromechanical (FME) industries, the best channels for sourcing new partners, and a ranking of the top companies in industry-academia partnerships. February 7, 2025 Share WhatsApp Twitter Linkedin Email Produced by Inpart
Podcast 7 Feb 2025Targeting the dark genome to develop new therapies to fight obesity This week, our podcast guest is Samir Ounzain, CEO of Haya Therapeutics. Ounzain was one of the first researchers to publish on lncRNA, also known as the ‘dark genome.’ February 7, 2025 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
News and Trends 6 Feb 2025 Top biotech deals of January 2025 January 2025 kicked off in full swing with several biotech deals in the biopharma industry. February 6, 2025 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 5 Feb 2025 Needle-free vaccines: Micron Biomedical, Vaxxas, and IntegriMedical bring their new technologies to patients Discover the advantages of needle-free vaccines and which companies are developing their own promising delivery solutions in this space. February 5, 2025 - 11 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 4 Feb 2025 World Cancer Day: trends in cancer therapeutics to look forward to in 2025 As we observe World Cancer Day today, let us look at some of the trends in cancer therapeutics expected to improve cancer care in 2025. February 4, 2025 - 14 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 4 Feb 2025 Akribion Therapeutics emerges from stealth with programmable cell depletion RNA technology Akribion Therapeutics emerges from stealth with €8 million in seed funding to develop a novel cancer RNA-guided approach February 4, 2025 - 6 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email